Paul W Maffuid's Net Worth
$142 Thousand
Who is Paul W Maffuid?
Paul W Maffuid does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ARENA PHARMACEUTICALS INC, and MABVAX THERAPEUTICS HOLDINGS, INC..
SEC CIK
Paul W Maffuid's CIK is 0001170363
Past Insider Trading and Trends
2017 was Paul W Maffuid's most active year for acquiring shares with 7 total transactions. Paul W Maffuid's most active month to acquire stocks was the month of March. 2017 was Paul W Maffuid's most active year for disposing of shares, totalling 10 transactions. Paul W Maffuid's most active month to dispose stocks was the month of March. 2015 saw Paul W Maffuid paying a total of $768,200.00 for 668,000 shares, this is the most they've acquired in one year. In 2018 Paul W Maffuid cashed out on 557,037 shares for a total of $137,329.96, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARENA PHARMACEUTICALS INC No price found
VP, Pharmaceutical DevelopmentPaul W Maffuid owns 16,496 units of Common Stock.acquired a total of 552 shares in ARENA PHARMACEUTICALS INC at a cost of $2,765.52.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.66% | 108 |
$4.64 | $501.12 | 16.5K |
Jun 30
| |||
Form 4
| +1.20% | 194 |
$5.10 | $989.40 | 16.39K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
| +0.55% | 88 |
$5.10 | $448.80 | 16.19K |
Dec 31
| |||
Form 4
| +1.02% | 162 |
$5.10 | $826.20 | 16.11K |
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MABVAX THERAPEUTICS HOLDINGS, INC. No price found
EXEC. VP, R AND DPaul W Maffuid owns 99,877 units of Common Stock. From 2014 to 2018 Paul W Maffuid acquired a total of 545,940 shares in MABVAX THERAPEUTICS HOLDINGS, INC. at a cost of $4,999.75, Paul also disposed a total of 192,670 shares of MABVAX THERAPEUTICS HOLDINGS, INC. equalling to $150,154.57.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.40% | 3.28K |
—
|
—
| 99.88K |
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| -11.83% | -38.05K |
$0.92 | -$35,009.68 | 283.7K |
Jan 16
| |||
Form 4
| +1,415.86% | 300.53K |
$0.97 | -$102,320.28 | 321.76K |
Jan 8 - Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
| +28.67% | 6.08K |
$1.75 |
—
| 27.31K |
May 19
| |||
Form 4
| -6.06% | -1.37K |
$2.00 | -$2,738.14 | 21.23K |
Apr 12
| |||
Form 4
| -4.44% | -1.05K |
$2.00 | -$2,102.25 | 22.59K |
Apr 7 - Apr 11
| |||
Form 4
| -13.43% | -3.67K |
$2.18 | -$7,984.22 | 23.64K |
Apr 4 - Apr 6
| |||
Form 4
| +122.65% | 15.04K |
—
|
—
| 27.31K |
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 29
| |||
Form 4
| +20.41% | 2.08K |
—
|
—
| 12.27K |
Aug 17
| |||
Form 4
| +1,407.80% | 70.39K |
—
|
—
| 75.39K |
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||